Inbound Relationships |
Type |
Active |
Source |
Characteristic |
Refinability |
Group |
Product containing levetiracetam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 100 mg/mL oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Serum levetiracetam measurement (procedure) |
Component |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
2 |
Levetiracetam 100mg/mL s/f oral solution |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 100mg/mL injection solution 5mL vial |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam-containing product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing levetiracetam in parenteral dose form (medicinal product form) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
|
Levetiracetam 1 g oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 1 g oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 500 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 500 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 250 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 250 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 750 mg oral tablet |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 750 mg oral tablet |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 750 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 1 g oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 500 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 250 mg oral tablet |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 500 milligram/5 milliliter conventional release solution for injection vial |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 500 milligram/5 milliliter conventional release solution for injection vial |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
False |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing only levetiracetam (medicinal product) |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam only product in oral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam only product in parenteral dose form |
The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 100 mg/mL solution for injection |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 100 mg/mL solution for injection |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 500 milligram/1 each prolonged-release oral tablet (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 100 mg/mL oral solution |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Levetiracetam 100 mg/mL oral solution |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 10 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 5 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 15 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 15 milligram/1 milliliter conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 100 milligram/1 milliliter concentrate for conventional release solution for infusion (clinical drug) |
The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Product containing precisely levetiracetam 100 milligram/1 milliliter concentrate for conventional release solution for infusion (clinical drug) |
This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |
Serum levetiracetam measurement (procedure) |
Component |
True |
Levetiracetam (substance) |
Inferred relationship |
Some |
1 |